Two and a half years of clinical experience with six month subcutaneous leuprolide acetate treatment for pubertal suppression in three boys

被引:0
|
作者
Sabanosh, Kristin [1 ]
Atkinson, Stuart N. [2 ]
Boldt-Houle, Deborah M. [2 ]
Daugherty, Rhea [2 ]
O'Brien, Mark [2 ]
Silverman, Lawrence A. [1 ]
机构
[1] Goryeb Childrens Hosp, Pediat Endocrinol, Morristown, NJ USA
[2] Tolmar Inc, Med Affairs, Buffalo, IL USA
关键词
D O I
10.1016/j.pedn.2024.04.020
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:245 / 245
页数:1
相关论文
共 9 条
  • [1] OVER TWO AND A HALF YEARS LONGITUDINAL ANALYSIS OF SIX MONTH SUBCUTANEOUS LEUPROLIDE ACETATE TREATMENT FOR PUBERTAL SUPPRESSION IN THREE BOYS
    Silverman, Lawrence
    Atkinson, Stuart
    Boldt-Houle, Deborah
    Daugherty, Rhea
    O'Brien, Mark
    Sabanosh, Kristin
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 104 - 105
  • [2] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty
    Matushek, Jori
    Atkinson, Stuart N.
    Boldt-Houle, Deborah M.
    Daugherty, Rhea
    OBrien, Mark
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77
  • [3] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty
    Matushek, Jori
    Atkinson, Stuart N.
    Boldthoule, Deborah M.
    Daugherty, Rhea
    O'Brien, Mark
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77 : 241 - 242
  • [4] Clinical experience with 6-month subcutaneous leuprolide acetate for central precocious puberty
    Matushek, Jori
    Boldt-Houle, Deborah M.
    Atkinson, Stuart N.
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2023, 72 : 202 - 203
  • [5] Unstimulated Luteinizing Hormone for Assessment of Suppression during Treatment of Central Precocious Puberty with 6-Month Subcutaneous Leuprolide Acetate: Correlations with Clinical Response
    Klein, Karen O.
    Miller, Bradley S.
    Mauras, Nelly
    HORMONE RESEARCH IN PAEDIATRICS, 2024,
  • [6] 36-Month Treatment Experience of Two Doses of Leuprolide Acetate 3-Month Depot for Children With Central Precocious Puberty
    Lee, Peter A.
    Klein, Karen
    Mauras, Nelly
    Lev-Vaisler, Tali
    Bacher, Peter
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09): : 3153 - 3159
  • [7] 6-Month Subcutaneous Leuprolide Acetate Achieved and Maintained Hormonal and Clinical Suppression in All Weight Groups of Children with Central Precocious Puberty
    Silverman, Lawrence
    Atkinson, Stuart
    Boldt-Houle, Deborah
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 285 - 287
  • [8] An eight-month clinical study of LA-2575 30.0 mg: A new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer
    Sartor, O
    Dineen, MK
    Perez-Marreno, R
    Chu, FM
    Carron, GJ
    Tyler, RC
    UROLOGY, 2003, 62 (02) : 319 - 323
  • [9] A 12-month clinical study of LA-2585 (45.0 MG): A new 6-month subcutaneous delivery system for Leuprolide acetate for the treatment of prostate cancer
    Crawford, ED
    Sartor, O
    Chu, F
    Perez, R
    Karlin, G
    Garrett, JS
    JOURNAL OF UROLOGY, 2006, 175 (02): : 533 - 536